The Patent Finder

Nantcell, Inc.

Also on record
Records under this name other than the patents Nantcell, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 45 patents it holds.

Back to Nantcell, Inc.

PatentTitleStatus Expires Confidence
US 11,154,597Sequence Arrangements and Sequences for Neoepitope Presentation
Formerly held
In force
 · High confidence
In forceHigh confidence
US 11,071,774Nant Cancer Vaccine
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 11,207,392Coordinated Multi-Prong Cancer Therapy
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 11,439,697Nant Cancer Vaccine
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 11,585,805Methods of Immunogenic Modulation
Formerly held
In force
 · High confidence
In forceHigh confidence
US 11,318,201Multimeric IL-15-Based Molecules
Formerly held
In force
 · High confidence
In forceHigh confidence
US 11,369,679Multimeric IL-15-Based Molecules
Formerly held
In force
 · High confidence
In forceHigh confidence
US 11,229,668Maximizing T-Cell Memory and Compositions and Methods Therefor
Formerly held
In force
 · High confidence
In forceHigh confidence
US 11,221,328Hypoxic NK Cells and Methods Therefor
Formerly held
In force
 · High confidence
In forceHigh confidence
US 11,573,230Rapid Verification of Virus Particle Production for a Personalized Vaccine
Formerly held
In force
 · High confidence
In forceHigh confidence
10 of 16 patents shown.
Pro members see all 16.
Pro members: see all 16 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited